Financial statements Gilead Sciences Poland
Cash flow statement of Gilead Sciences Poland
Company age:
Age:
15 y. 9 m. 14 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of GILEAD SCIENCES POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -131 750 641,42 | 23 451 655,09 | 106 253 919,54 | -102 624 097,44 | -14 542 395,48 | 118 646 568,93 |
| Net cash flow from investing activities | -126 574,85 | -2 494 624,45 | -278 502,15 | -128 226,00 | -901 189,57 | 0,00 |
| Net cash flow from financial activities | -1 264 176,17 | 623 159,04 | -1 420 525,88 | -1 424 778,15 | -1 726 830,90 | -1 519 902,77 |
| Total net cash flow | -133 141 392,44 | 21 580 189,68 | 104 554 891,51 | -104 177 101,59 | -17 170 415,95 | 117 126 666,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.